Carcinoma in Situ of the Bladder

Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples

1991 • 891 citations

A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the Bladder

1991 • 605 citations

Non-Invasive Papillary Carcinoma of the Bladder Associated with Carcinoma in Situ

1976 • 450 citations

Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer

1985 • 300 citations

Carcinoma in situ.

1992 • 292 citations

Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder.

1990 • 252 citations

Superficial Bladder Cancer Treated with Bacillus Calmette-Guerin: A Multivariate Analysis of Factors Affecting Tumor Progression

1989 • 250 citations

Genetic alterations in bladder cancer

1993 • 243 citations

Histological Study of Vesical Urothelium Intervening Between Gross Neoplasms in Total Cystectomy

1952 • 243 citations

Molecular genetic alterations in superficial and locally advanced human bladder cancer.

1991 • 233 citations

Long-Term Effect of Intravesical Bacillus Calmette-Guerin on Flat Carcinoma in Situ of the Bladder

1986 • 233 citations

Association of P53 Nuclear Overexpression and Tumor Progression in Carcinoma in situ of the Bladder

1994 • 221 citations

Natural history and clinical behavior of in situ carcinoma of the human urinary bladder

1964 • 213 citations

Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: A 10-Year Followup

1992 • 210 citations

Intra-Urothelial Cancer: Carcinoma In Situ, Bowen’s Disease of the Urinary System: Discussion of Thirty Cases

1952 • 195 citations

The Plight of the Patient with Carcinoma in Situ of the Bladder

1970 • 192 citations

Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy.

1976 • 191 citations

Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder.

1977 • 181 citations

Bacillus Calmette-Guerin Versus Doxorubicin Versus Thiotepa: A Randomized Prospective Study in 202 Patients with Superficial Bladder Cancer

1990 • 179 citations

CYTOLOGIC AND HISTOLOGIC FEATURES OF SUPERFICIAL BLADDER CANCER

1992 • 177 citations

Management of Stage T1 Superficial Bladder Cancer with Intravesical Bacillus Calmette-Guerin Therapy

1992 • 168 citations

Role of chromosome 9 in human bladder cancer.

1993 • 166 citations

The Use of Bacillus Calmette-Guerin in the Therapy of Bladder Carcinoma in Situ

1985 • 163 citations

The Use of Intravesical Thio-Tepa in the Management of Non-invasive Carcinoma of the Bladder

1981 • 163 citations

Prostatic Involvement by Transitional Cell Carcinoma: Pathogenesis, Patterns and Prognosis

1977 • 163 citations

Radical Cystectomy - Often Too Late?

1987 • 158 citations

Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: Effect of Bacillus Calmette-Guerin Viability on Treatment Results

1985 • 150 citations

Muscularis Mucosa of Urinary Bladder Importance for Staging and Treatment

1987 • 149 citations

The Role of Radical Cystectomy in the Management of High Grade Superficial Bladder Cancer (PA, P1PIS and P2)

1990 • 134 citations

Results of 6 Weekly Intravesical Bacillus Calmette-Guerin Instillations on the Treatment of Superficial Bladder Tumors

1988 • 134 citations

Histology and fine structure of the muscularis mucosae of the human urinary bladder.

1983 • 125 citations

Durability of the Tumor-Free Response for Intravesical Bacillus Calmette-Guerin Therapy

1994 • 114 citations

The Management of Superficial Bladder Tumors and Carcinoma in situ with Intravesical Bacillus Calmette-Guerin

1985 • 113 citations

Long-term Fate of 90 Patients with Superficial Bladder Cancer Randomly Assigned to Receive or not to Receive Thiotepa

1983 • 111 citations

Enhanced Bladder Cancer Detection with the Lewis X Antigen as a Marker of Neoplastic Transformation

1990 • 105 citations

Long-Term Followup of Patients Treated With 1 or 2, 6-Week Courses of Intravesical Bacillus Calmette-Guerin: Analysis of Possible Predictors of Response Free of Tumor

1990 • 103 citations

Growth Fractions of Transitional Cell Carcinomas of the Bladder Defined by the Monoclonal Antibody KI-67

1990 • 99 citations

Detection of Autocrine Motility Factor in Urine as a Marker of Bladder Cancer

1988 • 99 citations

Immunologic Indicators of Prognosis in Bladder Cancer: The Importance of Cell Surface Antigens

1980 • 94 citations

Bacillus Calmette-Guerin for Superficial Transitional Cell Carcinoma of the Bladder

1986 • 93 citations

Flat Carcinoma in situ of Bladder

1975 • 92 citations

The Clinical Significance of Carcinoma in Situ of the Bladder and its Association with Overt Carcinoma

1974 • 85 citations

Blood group-related antigens in human urothelium: enhanced expression of precursor, LeX, and LeY determinants in urothelial carcinoma.

1988 • 84 citations

Intravesical Therapy with Adriamycin in Patients with Superficial Bladder Tumors

1980 • 80 citations

Treatment of carcinoma in situ of the bladder with BCG

1980 • 79 citations

Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s)

1992 • 77 citations

Immunoanatomic distribution of blood group antigens in the human urinary tract. Influence of secretor status.

1986 • 71 citations

Controlled Clinical Trials in Urologic Oncology

1983 • 69 citations

Carcinoma In Situ: Comments on the Pathobiology of a Paradox

1980 • 68 citations

Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology Group.

1990 • 68 citations

Deoxyribonucleic Acid Profile and Tumor Progression in Primary Carcinoma in Situ of the Bladder: A Study of 63 Patients with Grade 3 Lesions

1992 • 65 citations

Ha-ras gene codon 12 mutation and DNA ploidy in urinary bladder carcinoma

1990 • 62 citations

Management of bladder cancer

1979 • 58 citations

Carcinoma in Situ of the Bladder

1995 • 57 citations

Urothelial tumors of upper tract following treatment of primary bladder transitional cell carcinoma

1992 • 57 citations

Intracavitary Doxorubicin Hydrochloride Therapy for Carcinoma in Situ of the Bladder

1981 • 56 citations

Carcinogenesis in the Human Urinary Bladder

1965 • 55 citations

Treatment of Superficial Bladder Cancer with Intravesical Mitomycin C: Analysis of Immediate and Long-Term Response in 70 Patients

1985 • 51 citations

Bacillus Calmette-Guerin for Treatment of Superficial Transitional Cell Carcinoma of the Bladder in Patients who have failed Thiotepa and/or Mitomycin C

1987 • 46 citations

Importance of early treatment of transitional cell carcinoma of prostatic ducts

1988 • 46 citations

Bladder caner from a perspective of 40 years

1992 • 45 citations

Mitomycin c intravesical therapy in noninvasive bladder cancer after failure on thiotepa

1984 • 44 citations

A Phase II Study of lntravesical Mitomycin C in the Treatment of Superficial Bladder Cancer

1983 • 42 citations

Outcome in Carcinoma in situ of Bladder Treated with Intravesical Bacille Calmette‐Guérin

1992 • 41 citations

Carcinoma-in-Situ of the Urothelium

1976 • 41 citations

Cytogenetic Studies of Carcinoma in Situ of the Bladder: Prognostic Implications

1992 • 38 citations

Management of Local Bacillus Calmette-Guerin Failures in Superficial Bladder Cancer

1992 • 35 citations

Long-term Follow-up in Patients with Superficial Bladder Tumours Treated with Intravesical Epodyl

1979 • 31 citations

Urine cytology in bladder tumors.

1991 • 30 citations

Paget’s Disease of the Urethral Meatus Following Transitional Cell Carcinoma of the Bladder

1986 • 29 citations

Prognostic significance of urine cytology on initial follow-up after intravesical mitomycin C for superficial bladder cancer

1986 • 28 citations

Intensive Intravesical Cheiviotherapy in the Treatment of Flat Carcinoma in Situ: Is it Safe?

1985 • 26 citations

Effect of Mitomycin C and Doxorubicin Instillation on Carcinoma in situ of the Urinary Bladder

1986 • 22 citations

Intravesical Mitomycin C for the Treatment of Recurrent Superficial Bladder Tumours

1987 • 22 citations

Immunotherapy of urological tumours

1989 • 20 citations

Intravesical combination chemotherapy with mitomycin C and doxorubicin for superficial bladder cancer: a randomized trial of maintenance versus no maintenance following a complete response

1992 • 20 citations

Markers of prognosis in superficial bladder cancer.

1992 • 19 citations

5-Year Experience with Intravesical Therapy of Carcinoma in Situ: An Inquiry Into the Risks of “Conservative” Management

1987 • 18 citations

Comparative Histopathology and Deoxyribonucleic Acid Flow Cytometry of Random Mucosal Biopsies in Untreated Bladder Carcinoma

1991 • 17 citations

Immunopathological effects of intravesical BCG therapy.

1989 • 16 citations

Long-term effect of intravesical bacillus Calmette-Guérin (BCG) Tice strain on flat carcinoma in situ of the bladder.

1989 • 16 citations

Local BCG Failures in Superficial Bladder Cancer

1991 • 16 citations

Topical Mitomycin C Therapy for Carcinoma in Situ of the Bladder: A Followup

1990 • 16 citations

The influence of Tice strain BCG treatment in patients with transitional cell carcinoma in situ.

1989 • 15 citations

Intravesical Adriamycin Therapy in Carcinoma in Situ of the Urinary Bladder

1984 • 14 citations

Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.

1989 • 14 citations

Chemotherapy in bladder carcinoma

1978 • 12 citations

The relationship of ABH(O) blood group antigen expression in intraepithelial dysplastic lesions to clinicopathologic properties of associated transitional cell carcinoma of the bladder

1991 • 12 citations

BCG in Superficial Bladder Cancer: A Review of Phase III European Trials

1992 • 11 citations

Urological Audit: the Role for an Aggressive Approach to High Grade Superficial Bladder Tumours

1992 • 8 citations

Urine or Bladder Washings in the Cytologic Evaluation of Transitional Cell Carcinoma of the Urinary Tract

1987 • 7 citations

Clinical assessment of carcinoma in situ of the human urinary bladder

1992 • 7 citations

Treatment of carcinoma in situ of the bladder with doxorubicin (Adriamycin)

1983 • 7 citations

Superficial bladder cancer treated by total cystectomy: Tumour characteristics and patient survival

1992 • 6 citations

Intravesical BCG therapy in patients with superficial bladder tumors.

1989 • 6 citations

Behavior of Epithelial Differentiation Antigens (Carcinoembryonic Antigen, Epithelial Membrane Antigen, Keratin and Cytokeratin) in Transitional Cell Carcinomas of the Bladder

1992 • 6 citations

Flow-Cytometric Deoxyribonucleic Acid Analysis of the Human Bladder Cancers with Reference to Histopathological Findings

1992 • 5 citations

Evaluation of clinical data in bladder cancer immunotherapy with Connaught BCG (ImmuCyst).

1992 • 2 citations